NHS引入更快的肺癌血液测试,每年可能帮助15,000名患者。 NHS introduces faster lung cancer blood test, potentially aiding 15,000 patients annually.

英格兰的国民保健体系正在推出新的血液测试,称为液体活性检查,可以更快地检测肺癌突变,每年可能帮助约15,000名病人。 The NHS in England is rolling out a new blood test, known as a liquid biopsy, which can detect lung cancer mutations faster, potentially helping about 15,000 patients annually. 这项测试使用血样来鉴定肿瘤DNA,避免组织组织活组织,将接受定向治疗的时间加快约16天。 This test uses a blood sample to identify tumor DNA, avoiding the need for tissue biopsies and speeding up access to targeted treatments by about 16 days. 它还可用于乳腺癌、胰腺癌和胆囊癌,预计每年可以节省1 100万英镑用于肺癌治疗。 It could also be used for breast, pancreatic, and gallbladder cancers, and is projected to save the NHS up to £11 million a year in lung cancer care.